| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-01-31 | FY 2023
FILED 2024-01-31 |
|---|---|---|---|
| Revenue (Total Sales) | $790.8M | $723.9M | $652.5M |
| YoY Revenue Growth % | +9.2% | +10.9% | — |
| Gross Profit | $704.0M | $646.7M | — |
| Gross Margin % | 89.0% | 89.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$197.3M | -$266.7M | -$270.0M |
| Operating Margin % | -25.0% | -36.8% | -41.4% |
| Net Income (GAAP) | -$189.0M | -$255.5M | -$257.0M |
| EBITDA (Normalized) | -$194.3M | -$262.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $90.4M | $14.9M | -$17.9M |
| Capital Expenditures (CapEx) | $3.8M | $5.6M | — |
| Free Cash Flow (FCF) | $86.6M | $9.4M | -$17.9M |
| FCF Margin % | 10.9% | 1.3% | -2.7% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $199.8M | $184.7M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $154.1M | $227.5M | — |